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After Percutaneous Coronary Intervention
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Tanvir Bajwa, MD, Suhail Allaqaband, MD
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Purpose	Obesity is a well-known risk factor for adverse cardiovascular events, but some studies suggest higher
body mass index (BMI) is associated with better outcomes after ST-segment elevation myocardial
infarction (STEMI). We sought to determine the effect of body surface area (BSA) on adverse events
after primary percutaneous coronary intervention (PCI) for STEMI and how this relates to the reported
obesity paradox theory.
Methods	
We analyzed a prospective registry of patients with STEMI who underwent primary PCI at a tertiary
care hospital from 2003 to 2009. Post-PCI complications and 1-year all-cause mortality were compared
across BSA quartiles. Relationship with 1-year mortality was compared between BSA and BMI using
logistic regression.
Results		Of 2,195 study patients (31.5% women), mean BSA and BMI were 2.0 ± 0.3 m2 and 29.2 ± 6.2 kg/m2,
respectively. The 1-year all-cause mortality from the lowest to highest quartiles of BSA was 11.0%, 6.5%,
5.5% and 5.1%, Ptrend<0.0001. Over a mean 5-year follow-up, there was a 76% relative risk reduction in
death for each 1 m2 increase in BSA. Higher BSA was associated with lower incidence of cardiogenic
shock, acute renal failure, coronary dissection and vascular and bleeding complications post-PCI. In
multivariate analysis, BSA remained strongly predictive of 1-year mortality (odds ratio 0.4 per m2 of BSA,
95% confidence interval 0.15–0.9), but BMI showed no independent association with mortality (odds ratio
0.99, 95% confidence interval 0.95–1.04).
Conclusions	
In STEMI patients undergoing primary PCI, high BSA is associated with lower mortality and complication
rates. BMI is not independently associated with 1-year mortality after adjusting for BSA and sex.
(J Patient-Centered Res Rev. 2015;2:9-16.)
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Primary percutaneous coronary intervention (PCI)
is the gold standard approach to reperfusion
therapy in patients with ST-segment elevation
myocardial infarction (STEMI) when there are no
contraindications.1 There are modifiable procedural
and clinical factors that affect the outcome of primary
PCI,2-4 but there also are patient characteristics like
sex5,6 and body mass index (BMI)7,8 that are associated
with PCI outcomes. Despite multiple studies that have
been done to determine the association between BMI
and the outcome of PCI, there are still conflicting data
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in this regard.9-12 For example, Sarno et al. studied
1,707 patients who underwent PCI and followed them
for one year.13 They found that BMI of >30 kg/m2 was an
independent factor for major cardiac events and stent
thrombosis irrespective of stent type. On the other hand,
a study of 6,560 patients with non-STEMI showed that
patients with high BMI had better 30-day outcomes
compared to patients with lower BMI, but the benefit
was not present after 30 days and both groups had the
same risk for primary endpoints (cardiovascular death,
myocardial infarction and recurrent ischemia) when
followed for one year.14
Obesity is a well-established risk factor for
cardiovascular disease,15 hence findings of better
prognosis in obese patients than in normal-weight
patients who are treated for heart failure, coronary
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disease and peripheral artery disease led to the term
“obesity paradox.”16-20 This suggests that obesity
is a marker for a different unidentified factor that
confers favorable cardiovascular outcomes. A positive
correlation has been shown between body surface
area (BSA), BMI and coronary artery size.8,21 The
calculations for BSA and BMI both use height and
weight, which could lead to confounding between the
two. BSA is reflective of body and organ sizes, whereas
BMI is a measure of body fat.22 It is unclear how BSA
relates to the “obesity paradox” debate. Particularly,
the effect of BSA on outcomes after primary PCI in
patients with STEMI has not been previously studied.
We hypothesized that patients with high BSA who
undergo primary PCI for STEMI will have a lower
rate of adverse outcomes than those with low BSA.
We also compared the strength of association between
mortality after primary PCI and BSA to the strength of
association with BMI.

METHODS

This was a nonrandomized, retrospective, registry-based
study designed to test the association between BSA and
clinical outcomes after PCI in patients presenting with
STEMI. Local institutional review board approval was
obtained prior to initiation of the study.
Patients and Variables
A consecutive population of all patients 18 years or
older who presented at our tertiary care hospital with
STEMI and were revascularized with primary PCI
from January 2003 to December 2009 were included
in the analysis. Data was extracted from the local
National Cardiovascular Data Registry (NCDR)
CathPCI Registry®. Hospital medical records were
reviewed and relevant clinical information manually
extracted for each patient. The National Death Index
was queried to identify all out-of-hospital deaths.
Standard NCDR data definitions (www.ncdr.com/
webncdr/cathpci) were used for all variables. The
main independent variables were BMI, BSA and sex.
BMI was calculated as weight (in kilograms)/height2
(in meters). The commonly used Mosteller formula
calculated BSA in m2 as √(weight x height/3600), with
weight in kilograms and height in meters.23 Outcome
variables assessed were in-hospital death, post-PCI
bleeding, coronary dissection, access-site vascular
complications, cardiogenic shock and acute renal
10
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failure as well as death from any cause within one
year. Adverse events were adjudicated by reviewing
patients’ electronic hospital records.
Data Analysis
There are no universal cut-offs for BSA, hence the
study sample was divided into quartiles of BSA and
data compared between quartiles. Continuous variables
were expressed as mean ± standard deviation and
compared using ANOVA. Categorical variables were
reported as percentages and compared using chi-square
test. Linear association among BSA quartile outcomes
was investigated using the linear applications of the
ANOVA and chi-square tests. Logistic regression was
used to compare outcomes across quartiles of BSA
adjusting for baseline patient comorbidities. Overall
survival was compared among quartiles of BSA using
Kaplan-Meier analysis and the log-rank test. Cox
proportional hazards regression was used to analyze
long-term survival. In survival analysis, time was
measured beginning from the index primary PCI. All
P-values were two-sided.

RESULTS

There were 2,197 patients who underwent primary
PCI for STEMI during the 7-year study period. Their
baseline characteristics are shown in Table 1. Mean
age was 61.5 ± 13.1 years, and there was a significant
trend for BSA to decrease with increasing age. There
was a strong association between sex and BSA. The
proportion of women per BSA quartile decreased
progressively from lowest to highest quartile. There
was a strong correlation between BSA and BMI.
Figure 1 shows that this correlation was strong in
both male and female patients. Interestingly, however,
at every level of BMI, BSA was higher in men than
in women. The frequency of hypertension, smoking,
prior myocardial infarction and prior PCI was similar
across all quartiles of BSA. Cardiac symptomatology
was similar between BSA quartiles, with about 82%
arriving within 6 hours of symptom onset and 7%
presenting with cardiogenic shock. Overall, 81% of
patients had door-to-balloon time of <90 minutes and
there was a small but statistically significant difference
between the lowest and highest quartiles. There was no
difference in the arterial territory or number of lesions
revascularized, or in the number of stents used. Mean
stent diameter increased with increasing BSA. There
was a significant correlation between BSA and stent
Original Research

Table 1. Baseline patient characteristics in all patients and according to quartile of body surface area
Body surface area, m2
Variable

All patients
(N=2,197)

<1.8
(n=437)

1.8 to 2
(n=590)

>2 to 2.2
(n=586)

>2.2
(n=584)

P*

Age (years), mean ± SD

61.5 ± 13.1

69.5 ± 13.9

63.3 ± 12.8

59.3 ± 11.5

55.9 ± 10.9

<0.001

Female, %

31.2

74.4

34.6

17.6

9.1

<0.001

29.2 ± 6.1

24.2 ± 6.0

27.1 ± 3.5

29.8 ± 4.5

34.5 ± 5.4

<0.001

Smoker, %

44.8

37.7

46.9

46.9

45.9

0.11

Hypertension, %

57.9

61.1

55.5

56.0

59.9

0.16

Dyslipidemia, %

62.0

55.2

60.1

65.4

65.6

0.001

Diabetes, %

16.9

15.8

14.9

15.5

21.1

0.05

Previous MI, %

16.0

19.8

14.9

15.2

14.9

0.12

Previous PCI, %

21.4

22.5

20.7

22.0

20.5

0.83

Previous CABG, %

5.6

5.7

7.5

6.3

2.7

0.004

BMI (kg/m2), mean ± SD

Symptom duration

0.28

≤6 hours, %

82.0

76.9

83.5

81.4

84.8

6–12 hours, %

8.7

11.0

8.2

8.6

7.7

9.3

12.1

8.2

10.1

7.5

Door-to-balloon time <90 min, %

>12 hours, %

81.1

76.4

81.7

83.3

81.8

0.04

Transfer patient, %

49.6

49.5

43.4

50.7

54.8

0.01

Cardiogenic shock, %

7.1

8.2

6.6

6.7

7.0

0.74

LVEF ≤40, %

33.2

40.4

34.3

30.8

29.3

0.04

Arteries revascularized†
Left main, %

0.5

0.7

0.2

0.7

0.7

0.55

Left anterior descending, %

38.3

41.0

38.0

35.8

39.0

0.39

Left circumflex, %

19.2

17.6

18.8

21.3

18.5

0.45

Right coronary, %

49.4

48.1

50.3

51.2

47.8

0.59

Lesions treated (n), mean ± SD

1.3 ± 0.6

1.3 ± 0.6

1.3 ± 0.6

1.4 ± 0.7

1.3 ± 0.5

0.16

Stents (n), mean ± SD

1.7 ± 1.0

1.6 ± 1.1

1.7 ± 1.2

1.7 ± 1.0

1.6 ± 0.9

0.53

Stent diameter (mm), mean ± SD

3.0 ± 0.5

2.9 ± 0.4

3.0 ± 0.4

3.1 ± 0.5

3.3 ± 0.3

<0.001

Bare-metal stent, %

46.6

49.0

44.7

45.1

48.3

0.39

Drug-eluting stent, %

41.1

34.6

43.4

43.9

41.1

0.01

Unknown stent type, %

12.2

16.5

11.9

11.1

10.6

0.02

*Two-tailed P-value calculated using chi-square test for categorical variables and ANOVA for continuous variables.
†

Adds up to more than 100% because some patients had more than one artery revascularized

BMI, body mass index; CABG, coronary artery bypass graft; LVEF, left ventricular ejection fraction; MI, myocardial
infarction; PCI, percutaneous coronary intervention; SD, standard deviation.

diameter (R=0.26, P<0.001). Using linear regression
analysis, stent diameter increased by 0.29 mm for each
1 m2 increase in BSA (95% confidence interval [CI]
0.2–0.37, P<0.001).
Overall angiographic success, defined as residual
stenosis of <30% with TIMI-3 flow, was 97.5%, and
was similar across all BSA quartiles (P=0.69). There
Original Research

were some significant differences in post-PCI clinical
outcomes between BSA quartiles (Figure 2). There
was a significant inverse linear relationship between
post-PCI complications and BSA quartile. The rate of
adverse events decreased from lowest (≤1.8 m2) to
highest BSA quartile (>2.2 m2). Although coronary
dissection was generally rare, it had the highest relative
increase, 27-fold from the highest BSA quartile to the
www.aurora.org/jpcrr
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lowest quartile. There was approximately a doubling
in the incidence of acute renal failure, vascular
complications (mainly pseudoaneurysms), bleeding
events and cardiogenic shock between the highest
and lowest BSA quartiles. The incidence of repeat
myocardial infarction prior to discharge was 0.8%
overall, without any difference between BSA quartiles
(P=0.16). The rates of emergency coronary artery
bypass surgery were 2.7%, 2.5%, 1.9% and 2.6% in the
lowest, second, third and highest quartiles, respectively
(P=0.95).
These differences in post-PCI complications were
accompanied by a significant decrease in mortality with
increasing BSA. In-hospital mortality was 7.4%, 4.6%,
3.4% and 3.4% in the lowest, second, third and highest
BSA quartiles, respectively (P=0.001). In patients with
STEMI, the better prognosis associated with high BSA
that is seen early after primary PCI persisted long term.
Figure 3 shows Kaplan-Meier survival curves for the
four quartiles of BSA. The 1-year overall survival rates
were 88.3%, 93.7%, 94.5% and 94.9% in the lowest,
second, third and highest BSA quartiles, respectively
(Ptrend<0.001). Over a mean follow-up period of 5 years
(range: 2–9 years), the hazard ratios of all-cause death
in the second, third and highest quartiles of BSA when
compared to the lowest quartile were 0.63 (95% CI
0.46–0.87), 0.48 (95% CI 0.34–0.68) and 0.43 (95%
CI 0.31–0.62). Considering BSA as a continuous
variable, there was a 76% relative risk reduction in
death for every 1 m2 increase in BSA (95% CI 61.0–
85.0, P<0.001).
We compared the strengths of association of BSA with
1-year mortality and the association of BMI with 1-year
mortality (Table 2). On univariate analysis, increases
in both BSA and BMI were associated with decreases
in 1-year mortality, but the association was stronger
with BSA than BMI. We performed multivariate
analysis adjusting for BSA, BMI and sex because all
three variables affect each other and mortality. We also
adjusted for age, symptom duration, shock, door-toballoon time, coronary anatomy and comorbidities.
BSA maintained a significant independent association
with 1-year mortality, but BMI and sex were no longer
associated with 1-year mortality.

12
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Figure 1. Correlation of body surface area with body

mass index among male and female patients. R stands
for correlation coefficient. Each data point represents
a patient. Lines represent the linear correlation
relationship.

Figure 2. Comparison of in-hospital adverse

events occurring after primary percutaneous coronary
intervention in patients with ST-elevation myocardial
infarction between quartiles of body surface area (BSA).

Original Research

term all-cause mortality also decreased with increasing
BSA. BMI was associated with 1-year mortality only
on univariate analysis. In the multivariate analysis,
only BSA remained associated with 1-year mortality
whereas BMI showed no independent effect.
Previous studies have investigated the association
between BMI and PCI outcomes in patients with acute
coronary syndromes and reported results that are in
conflict with the obesity paradox.7,8,12,24 In a study of
4,972 patients who underwent PCI with drug-eluting
stents, patients with higher BMI had a higher risk
of stent thrombosis compared to patients with lower
BMI; and after multivariate analysis, obesity was
still an independent predictor for thrombotic events.12
Similarly, Ellis et al. evaluated the association of
BMI and PCI outcomes on 3,571 patients and showed
BMI of >35 was associated with higher mortality.24
Figure 3. Kaplan-Meier curves comparing overall

survival between quartiles of body surface area (BSA).

DISCUSSION

In this study we divided 2,197 patients with STEMI
who underwent primary PCI into quartiles of BSA
and compared clinical outcomes between them. Going
form the lowest (<1.8 m2) to the highest quartile
(>2.2 m2) of BSA, there were significant reductions
in post-PCI complications like coronary dissection,
cardiogenic shock, acute renal failure, bleeding,
vascular complications and in-hospital death. Long-

Different mechanisms have been proposed to explain
these findings. First, obese patients have higher levels
of coagulation factors, including factors VII, VIII,
plasminogen activator inhibitor-1 and fibrinogen,
that make them relatively hypercoagulable.25,26
Periprocedural antithrombotic regimens may be
inadequate in very obese patients due to their unusual
weight.24,27 Other studies have paradoxically shown
that higher BMI was associated with better outcomes
in patients who undergo PCI, lending support to the
obesity paradox.8-11 Obesity has long been associated
with an increased risk of death from all causes,
diabetes mellitus, hypertension, dyslipidemia and
atherosclerosis.28,29 These well-documented adverse
outcomes of obesity lead us to think that the observation

Table 2. Relative strengths of association of body surface area and body mass index with 1-year mortality
Univariate
Variable

Multivariate adjusted*

Odds ratio

95% CI

P

Odds ratio

95% CI

P

Body surface area (m2)†

0.24

0.13-0.45

<0.0001

0.40

0.15-0.90

0.01

Body mass index (kg/m )

0.96

0.93-0.99

0.019

0.99

0.95-1.04

0.82

Male§

0.51

0.36-0.71

<0.0001

0.68

0.43-1.07

0.10

2 †

*Adjusted for listed variables plus age, symptom duration, shock, door-to-balloon time, coronary anatomy and comorbidities.
Odds ratios calculated per unit increase in body surface area or body mass index.

†
§

Compares male versus female.

CI, confidence interval.
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of better post-PCI outcomes in obese patients is due to
some other confounding factor. More recent studies
have questioned the validity of an obesity paradox in
patients treated with PCI. In the Swedish Coronary
Angiography and Angioplasty Study, there was a
biphasic relationship between BMI and mortality in
which mortality decreased with increasing BMI up to
35 kg/m2, after which mortality started to increase.30 A
recent study of patients with STEMI from the NCDR
registry also reported lower in-hospital mortality,
bleeding and adverse cardiac events with increasing
BMI, except for patients with BMI of >40 kg/m2, who
had worse prognosis.31 In this study, however, obese
patients were more likely to be younger and have less
extensive coronary artery disease. After adjustment
for baseline differences, there was no significant
difference in outcomes between normal-weight,
overweight and mildly obese patients, putting into
question the obesity paradox.
Our study also found that while mortality decreased
with increasing BMI on univariate analysis, BMI had
no effect on mortality on multivariate analysis that
adjusted for baseline confounders. BSA, on the other
hand, maintained a strong association with mortality
both in unadjusted and adjusted analyses. The strong
correlation we demonstrated between BSA and BMI
show the confounding effect they have on each other.
This leads us to propose that much of the previously
observed association between BMI and prognosis
after myocardial infarction or PCI can be attributed to
the confounding effect of BSA. We suggest that BSA
is the true independent predictor of outcomes after
primary PCI in patients with STEMI.
Although there are no studies that directly test the
effect of BSA on post-PCI outcomes, there have been
indirect inferences in recent literature. In a large study
based on the NCDR registry with an identical definition
of bleeding to ours, the bleeding risk after PCI was not
associated to BMI but was decreased with increase in
BSA.32 Bleeding risk of women was double that of
men (7.8% vs. 3.7%, P<0.01), which was attributable
in part to lower BSA of women. Similarly, Peterson
et al. evaluated 109,708 patients treated with PCI and
reported a higher risk for stroke, vascular complications
and in-hospital mortality in women than men, but there
was no difference in mortality after adjusting for BSA.5

14
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The authors concluded that BSA, rather than sex, is an
independent risk factor for post-PCI mortality. There
is a well-demonstrated association between high BSA
and better outcomes after coronary artery bypass
grafting (CABG). High BSA is associated with better
graft patency, leading to lower incidence of adverse
cardiac events after CABG.33 There is strong evidence
showing that BSA and coronary artery diameter are
inversely related with mortality rate in patients who
undergo CABG.34,35 Much of the reports of higher
mortality in women compared to men after CABG
have been attributed to the smaller BSA of women.36,37
The positive effect of BSA on coronary artery diameter,
cardiac size and blood volume may explain the effect
of BSA on post-PCI outcomes. In populations of
patients both with and without established coronary
artery disease, there is a significant increase in the
diameter of coronary arteries with increasing BSA
irrespective of sex.6,21 If stent diameter can be used as
a surrogate for coronary artery diameter, this will be
similar to our finding of a positive correlation between
stent diameter and BSA. In the PCI population, large
coronary diameter was associated with lower rates of
restenosis, repeat revascularization, stent thrombosis,
recurrent myocardial infarction and death.38,39 In the
general population, BSA has correlated positively
with other measures of heart size like left ventricular
mass, ventricular volumes and blood volume.40-42
Larger arteries also prevent sheath/artery mismatch,
which reduces access site complications. We theorize
that prognosis is better in patients with high BSA after
primary PCI following STEMI because they have more
myocardial and vascular reserve that can compensate
for the injury acutely as well as larger coronary arteries
that lower the risk of cardiac events.
Limitations
Our study reflects the experience of a tertiary care
center with a rare STEMI program that requires the
catheterization laboratory staff and interventional
cardiologist to remain in-house 24 hours/day, 7 days/
week.43 Although our overall event rates may be different
from other centers, we do not anticipate a different
relationship between BSA and major outcomes.
The use of a registry could introduce errors due to
missing data and inaccurate data entry. We manually
reviewed hospital records to crosscheck clinical
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outcomes on every patient. Bleeding complications
captured in our study were major ones associated with
drop in hemoglobin of ≥3 g/dL, blood transfusion
or procedural intervention to control bleeding. Less
significant bleeding events, albeit important, were
not captured. That said, our findings are valid and
constitute an important consideration for clinicians
when caring for patients with STEMI.

CONCLUSIONS

There is an inverse relationship between body surface
area and adverse clinical events in patients with
ST-segment elevation myocardial infarction who
undergo primary percutaneous coronary intervention.
Increase in BSA from the lowest to highest quartile was
associated with decreasing rates of short- and longterm mortality as well as decreasing rates of coronary
dissection, cardiogenic shock, acute renal failure,
bleeding and vascular complications. Body mass index
is not independently associated with 1-year mortality
after adjusting for BSA and sex. Clinicians should pay
attention to the increased risk of adverse outcomes in
patients with BSA of <1.8 m2, and consideration should
be given to including BSA in risk adjustment models
that compare clinical outcomes in patients undergoing
primary PCI for STEMI.
Patient-Friendly Recap
• A heart attack (myocardial infarction) occurs
when proper blood flow to the heart is stopped,
usually due to blockage in one or more coronary
arteries.
• Percutaneous coronary intervention (PCI) is a less
invasive procedure used to unclog arteries and
prevent further heart damage.
• Despite having an overall increased risk of
heart disease, obese patients seem to do better
following PCI.
• The authors report this “obesity paradox” can
be attributed to increased body surface area,
rather than body mass index (BMI) as previously
reported.
• Patients with more body surface area tend to have
wider arteries, which might explain why they
experience fewer complications from PCI.

Original Research
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